Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

Journal of General Virology

Volumn 91, Issue 7, 2010, Pages 1743-1753

  Bodewes, Rogier ^a   Kreijtz, Joost H C M ^a   Hillaire, Marine L B ^a   Geelhoed Mieras, Martina M ^a   Fouchier, Ron A M ^a   Osterhaus, Albert D M E ^a   Rimmelzwaan, Guus F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INACTIVATED VIRUS VACCINE; PROTEIN SUBUNIT; RNA POLYMERASE; EPITOPE; INFLUENZA VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNE RESPONSE; IMMUNITY; INFLUENZA; INFLUENZA VIRUS A H5N1; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; CYTOLOGY; GERMFREE ANIMAL; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; LUNG; PHYSIOLOGY; SPLEEN; VIROLOGY;

MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; VACCINATION;

EID: 77954171801     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.020784-0     Document Type: Article

References (56)

1. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. & Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
2. + T cell subsets identified by expression of IL-7 receptor a and CD62L. J Immunol 175, 4686-4696.
3. + T-cell response is much less apparent following secondary challenge. J Virol 74, 3486-3493.
4. Benton, K. A., Misplon, J. A., Lo, C. Y., Brutkiewicz, R. R., Prasad, S. A. & Epstein, S. L. (2001). Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells. J Immunol 166, 7437-7445.
5. Bevan, M. J. (2006). Cross-priming. Nat Immunol 7, 363-365.
6. Bodewes, R., Kreijtz, J. H. & Rimmelzwaan, G. F. (2009a). Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis 9, 784-788.
7. Bodewes, R., Kreijtz, J. H., Baas, C., Geelhoed-Mieras, M. M., de Mutsert, G., van Amerongen, G., van den Brand, J. M., Fouchier, R. A., Osterhaus, A. D. & other authors (2009b). Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One 4, e5538.
8. Carragher, D. M., Kaminski, D. A., Moquin, A., Hartson, L. & Randall, T. D. (2008). A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 181, 4168-4176.
9. Cassetti, M. C., Couch, R., Wood, J. & Pervikov, Y. (2005). Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004. Vaccine 23, 1529-1533.
10. Centers for Disease Control and Prevention (2009). Update: infections with a swine-origin influenza A (H1N1) virus - United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep 58, 431-433.
11. Chan, M. (2009). World Now at the Start of 2009 Influenza Pandemic. Statement to the press by the World Health Organization directorgeneral. Available at http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html.
12. + T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination. J Immunol 173, 5021-5027.
13. + T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 198, 399-410.
14. Doherty, P. C., Biddison, W. E., Bennink, J. R. & Knowles, B. B. (1978). Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med 148, 534-543.
15. Epstein, S. L. (2006). Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 193, 49-53.
16. Epstein, S. L., Lo, C. Y., Misplon, J. A., Lawson, C. M., Hendrickson, B. A., Max, E. E. & Subbarao, K. (1997). Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, b2-microglobulin-deficient, and J chain-deficient mice. J Immunol 158, 1222-1230.
17. Fiore, A. E., Shay, D. K., Broder, K., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., Cox, N. S. & other authors (2008). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57, 1-60.
18. + T cells in primary and secondary influenza pneumonia. Immunity 8, 683-691.
19. Frank, A. L., Puck, J., Hughes, B. J. & Cate, T. R. (1980). Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol 12, 426-432. (Pubitemid 10054038)
20. Grebe, K. M., Yewdell, J. W. & Bennink, J. R. (2008). Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect 10, 1024-1029.
21. Greenbaum, J. A., Kotturi, M. F., Kim, Y., Oseroff, C., Vaughan, K., Salimi, N., Vita, R., Ponomarenko, J., Scheuermann, R. H. & other authors (2009). Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106, 20365-20370.
22. + memory T cells by viral variants. J Exp Med 190, 1319-1328.
23. Heikkinen, T. & Peltola, V. (2009). Influenza vaccination of children. Lancet Infect Dis 9, 720-721.
24. Heikkinen, T., Booy, R., Campins, M., Finn, A., Olcen, P., Peltola, H., Rodrigo, C., Schmitt, H. J., Schumacher, F. & other authors (2006). Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr 165, 223-228.
25. + T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 162, 7578-7583.
26. Jegerlehner, A., Schmitz, N., Storni, T. & Bachmann, M. F. (2004). Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172, 5598-5605. (Pubitemid 38542062)
27. Kaiser, J. (2006). A one-size-fits-all flu vaccine? Science 312, 380-382.
28. Karber, G. (1931). Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch Pharmacol 162, 480-483.
29. Kreijtz, J. H., Bodewes, R., van Amerongen, G., Kuiken, T., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2007). Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 25, 612-620. (Pubitemid 44856111)
30. Kreijtz, J. H., de Mutsert, G., van Baalen, C. A., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2008). Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82, 5161-5166.
31. Kreijtz, J. H., Bodewes, R., van den Brand, J. M., de Mutsert, G., Baas, C., van Amerongen, G., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2009). Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 27, 4983-4989.
32. Lee, L. Y., Ha, D. L., Simmons, C., de Jong, M. D., Chau, N. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J. J. & other authors (2008). Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118, 3478-3490.
33. Liang, S., Mozdzanowska, K., Palladino, G. & Gerhard, W. (1994). Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 152, 1653-1661. (Pubitemid 24075695)
34. McMichael, A. J., Gotch, F. M., Noble, G. R. & Beare, P. A. (1983). Cytotoxic T-cell immunity to influenza. N Engl J Med 309, 13-17.
35. Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E. & Randall, T. D. (2004). Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10, 927-934.
36. Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M. & Fiers, W. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5, 1157-1163.
37. + cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254, 50-60.
38. Nguyen, H. H., van Ginkel, F. W., Vu, H. L., Novak, M. J., McGhee, J. R. & Mestecky, J. (2000). Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice. J Virol 74, 5495-5501.
39. + cytotoxic T lymphocytes. J Infect Dis 183, 368-376.
40. Nguyen, H. H., Zemlin, M., Ivanov, I. I., Andrasi, J., Zemlin, C., Vu, H. L., Schelonka, R., Schroeder, H. W., Jr & Mestecky, J. (2007). Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol 81, 9331-9338.
41. O'Neill, E., Krauss, S. L., Riberdy, J. M., Webster, R. G. & Woodland, D. L. (2000). Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J Gen Virol 81, 2689-2696.
42. Palmer, D., Dowle, W., Coleman, M. & Schild, G. (1975). Haemagglutination inhibition test. In Advances in Laboratory Techniques for Influenza Diagnosis: Procedural Guide, pp. 25-62. Atlanta: US Department of Health, Education and Welfare.
43. Powell, T. J., Strutt, T., Reome, J., Hollenbaugh, J. A., Roberts, A. D., Woodland, D. L., Swain, S. L. & Dutton, R. W. (2007). Priming with cold-adapted influenza A does not prevent infection but elicits longlived protection against supralethal challenge with heterosubtypic virus. J Immunol 178, 1030-1038.
44. Rangel-Moreno, J., Carragher, D. M., Misra, R. S., Kusser, K., Hartson, L., Moquin, A., Lund, F. E. & Randall, T. D. (2008). B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms. J Immunol 180, 454-463.
45. Schulman, J. L. & Kilbourne, E. D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J Bacteriol 89, 170-174.
46. Slepushkin, V. A., Katz, J. M., Black, R. A., Gamble, W. C., Rota, P. A. & Cox, N. J. (1995). Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13, 1399-1402.
47. Sonoguchi, T., Naito, H., Hara, M., Takeuchi, Y. & Fukumi, H. (1985). Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 151, 81-88. (Pubitemid 15192884)
48. Straight, T. M., Ottolini, M. G., Prince, G. A. & Eichelberger, M. C. (2008). Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats. Virol J 5, 44.
49. Taylor, P. M. & Askonas, B. A. (1986). Influenza nucleoproteinspecific cytotoxic T-cell clones are protective in vivo. Immunology 58, 417-420.
50. Tumpey, T. M., Renshaw, M., Clements, J. D. & Katz, J. M. (2001). Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75, 5141-5150.
51. Webster, R. G. & Askonas, B. A. (1980). Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 10, 396-401.
52. Wells, M. A., Ennis, F. A. & Albrecht, P. (1981). Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol 126, 1042-1046. (Pubitemid 11155752)
53. World Health Organization (2009). Influenza (Seasonal), Fact Sheet No. 211. Available at http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
54. World Health Organization (2010). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. Available at http://www.who.int/csr/disease/avian-influenza/country/cases-table-2010-03-16/ en/index.html. Site accessed March 16, 2010.
55. Yap, K. L., Ada, G. L. & McKenzie, I. F. (1978). Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238-239.
56. Yetter, R. A., Barber, W. H. & Small, P. A., Jr (1980). Heterotypic immunity to influenza in ferrets. Infect Immun 29, 650-653.